Our track record
Our strong cash generation from our sustainable and growing brands, combined with our efficient virtual business model, has allowed the financial support from our banking partners and public investors. This enables us to transact with confidence.
We have an excellent track record of deal-making:
- Completed over 35 deals in 20 years
- Acquired a range of International Star and Local brands
- A mix of larger strategic/transformational deals (Cambridge Labs, Sinclair Pharma's healthcare products and Nizoral™ in APAC) and smaller bolt-on acquisitions
Below you'll find some recent highlights of successful partnerships.
The Kelo-Cote™ Story
Ashton & Parsons™
INT/3926/09.19/0.001